Hubei Keyi Pharmaceutical

Hubei Keyi Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the Humanwell Healthcare Group. Based in Wuhan, the company focuses on the development and production of high-quality chemical drugs, with a particular emphasis on antiviral, anti-infective, and cardiovascular therapies. It is widely recognized as a leading producer of Ganciclovir and Acyclovir, maintaining significant market share in the antiviral segment within China. The company operates state-of-the-art GMP-certified facilities and integrates R&D, manufacturing, and commercialization capabilities. Hubei Keyi's portfolio includes a wide range of formulations such as injections, tablets, and capsules, serving both domestic and international markets.